HIV case administration utilizing agent-based modeling method topic to antiretroviral remedy and life-style remedy plan

Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. Hiv-1 dynamics in vivo: virion clearance price, contaminated cell life-span, and viral technology time. Science 271(5255), 1582–1586. (1996).

Google Scholar 

Rivadeneira, P. S. et al. Mathematical modeling of hiv dynamics after antiretroviral remedy initiation: A evaluate. Biores. Open Access 3(5), 233–241. (2014).

Google Scholar 

Perelson, A. S. et al. Decay traits of hiv-1-infected compartments throughout mixture remedy. Nature 387(6629), 188–191. (1997).

Google Scholar 

Rasi, G., Emili, E., Conway, J. M., Cotugno, N. & Palma, P. Mathematical modeling and mechanisms of hiv latency for customized anti latency therapies. NPJ Syst. Biol. Appl. 11(1), 64. (2025).

Google Scholar 

Jin, R. & Zhang, L. Ai purposes in hiv analysis: advances and future instructions. Front. Microbiol. 16, 1541942. (2025).

Google Scholar 

Sadee, W., Wang, D., Hartmann, Ok. & Toland, A. E. Pharmacogenomics: Driving customized medication. Pharmacol. Rev. 75(4), 789–814. (2023).

Google Scholar 

Rosenbloom, D. I., Hill, A. L., Rabi, S. A., Siliciano, R. F. & Nowak, M. A. Antiretroviral dynamics determines hiv evolution and predicts remedy end result. Nat. Med. 18(9), 1378–1385. (2012).

Google Scholar 

Rong, L., Feng, Z. & Perelson, A. S. Emergence of hiv-1 drug resistance throughout antiretroviral remedy. Bull. Math. Biol. 69(6), 2027–2060. (2007).

Google Scholar 

Callaway, D. S. & Perelson, A. S. Hiv-1 an infection and low regular state viral hundreds. Bull. Math. Biol. 64(1), 29–64. (2002).

Google Scholar 

Rong, L. & Perelson, A. S. Modeling hiv persistence, the latent reservoir, and viral blips. J. Theor. Biol. 260(2), 308–331. (2009).

Google Scholar 

Coffin, J. M. Hiv inhabitants dynamics in vivo: implications for genetic variation, pathogenesis, and remedy. Science 267(5197), 483–489. (1995).

Google Scholar 

Pham, P. A. & Gallant, J. E. Tenofovir disoproxil fumarate for the remedy of hiv an infection. Expert Opin. Drug Metab. Toxicol. 2(3), 459–469. (2006).

Google Scholar 

Fiebig, E. W. et al. Dynamics of hiv viremia and antibody seroconversion in plasma donors: implications for prognosis and staging of major hiv an infection. AIDS 17(13), 1871–1879. (2003).

Google Scholar 

Pantaleo, G. et al. Hiv an infection is energetic and progressive in lymphoid tissue throughout the clinically latent stage of illness. Nature 362(6418), 355–358. (1993).

Google Scholar 

Adams, B. M. et al. Hiv dynamics: Modeling knowledge evaluation, and optimum remedy protocols. J. Comput. Appl. Math. 184(1), 10–49. (2007).

Google Scholar 

Ribeiro, R. M. & Bonhoeffer, S. Production of resistant hiv mutants throughout antiretroviral remedy. Proc. Natl. Acad. Sci. 97(14), 7681–7686. (2008).

Google Scholar 

Komarova, N. L. & Wodarz, D. Drug resistance in most cancers: rules of emergence and prevention. Proc. Natl. Acad. Sci. 102(27), 9714–9719. (2009).

Google Scholar 

Zhang, X. et al. Agent-based modeling of epidemics: Approaches, purposes, and future instructions. Technologies 13(7), 272. (2025).

Google Scholar 

Sun, R. & Bai, Z. The software of simulation strategies throughout the covid-19 pandemic: A scoping evaluate. J. Biomed. Inform. 148(7), 104543. (2023).

Google Scholar 

Lukens, S. et al. A big-scale immuno-epidemiological simulation of influenza a epidemics. BMC Public Health 14, 1019. (2014).

Google Scholar 

De-Leon, D. & Aran, H. Mam: Flexible monte-carlo agent primarily based mannequin for modelling covid-19 unfold. J. Biomed. Inform. 141, 104364. (2023).

Google Scholar 

Hinch, W. et al. Openabm-covid19—an agent-based mannequin for non-pharmaceutical interventions in opposition to covid-19 together with contact tracing. PLoS Comput. Biol. 17, e1009146. (2021).

Google Scholar 

Seresht, N. Enhancing resilience in development in opposition to infectious ailments utilizing stochastic multi-agent method. Autom. Constr. 140, 104315. (2022).

Google Scholar 

Jenness, S., Johnson, J., Hoover, Ok., Smith, D. & Delaney, Ok. Modeling an built-in hiv prevention and care continuum to realize the ending the hiv epidemic objectives. AIDS 34(14), 2103–2113. (2022).

Google Scholar 

Nosyk, B. et al. Ending the hiv epidemic within the USA: an financial modelling examine in six cities. The Lancet HIV 7(7), e491–e503. (2020).

Google Scholar 

Vermeer, W. et al. Agent-based mannequin projections for decreasing hiv an infection amongst msm: Prevention and care pathways to finish the hiv epidemic in chicago, illinois. PLoS ONE 17(10), e0274288. (2022).

Google Scholar 

Cremin, I. et al. The new function of antiretrovirals together hiv prevention: a mathematical modelling evaluation. AIDS 27(3), 447–458. (2013).

Google Scholar 

Granich, R. M., Gilks, C. F., Dye, C., De Cock, Ok. M. & Williams, B. G. Universal voluntary hiv testing with speedy antiretroviral remedy as a technique for elimination of hiv transmission: a mathematical mannequin. The Lancet 373(9657), 48–57. (2009).

Google Scholar 

Eaton, J. W. et al. Hiv remedy as prevention: systematic comparability of mathematical fashions of the potential impression of antiretroviral remedy on hiv incidence in south africa. PLoS Med. 9(7), e1001245. (2012).

Google Scholar 

Mansky, L. M. & Temin, H. M. Lower in vivo mutation price of human immunodeficiency virus sort 1 than that predicted from the constancy of purified reverse transcriptase. J. Virol. 69(8), 5087–5094. (1995).

Google Scholar 

Chun, T. W. et al. In vivo destiny of hiv-1-infected t cells: quantitative evaluation of the transition to steady latency. Nat. Med. 1(12), 1284–1290. (1995).

Google Scholar 

CDC. Revised surveillance case definition for hiv an infection—United States, 2014. Morb. Mortal. Wkly. Rep. 63, 1–10 (2014).

Google Scholar